80.38

0.73% 0.58

After Hours: 80.38

Haemonetics Corp (HAE)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Haemonetics Corp stock is traded at $80.38, with a volume of 578.49K. It is up +0.73% in the last 24 hours and up +6.35% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Previous Close:

$79.80

Open:

$79.84

24h Volume:

578.49K

Relative Volume:

1.00

Market Cap:

$4.06B

Revenue:

$1.27B

Net Income/Loss:

$126.57M

P/E Ratio:

32.28

EPS:

2.49

Net Cash Flow:

$128.75M

1W Performance:

+5.24%

1M Performance:

+6.35%

6M Performance:

-5.82%

1Y Performance:

-10.27%

1-Day Range:

$79.24

$80.66

1-Week Range:

$74.98

$80.66

52-Week Range:

$70.74

$97.97

Haemonetics Corp Stock (HAE) Company Profile

Name

Haemonetics Corp

Sector

Healthcare (1190)

Industry

Medical Instruments & Supplies (58)

Phone

(781) 848-7100

Address

125 SUMMER STREET, BOSTON, MA

Employee

3,657

Twitter

@HaemoneticsCorp

Next Earnings Date

2024-08-08

Latest SEC Filings

HAE's Discussions on Twitter

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-13-22	Initiated	Mizuho	Buy
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral
Aug-17-21	Resumed	Raymond James	Outperform
Jun-17-21	Initiated	Citigroup	Buy
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy
Aug-07-19	Reiterated	Barrington Research	Outperform
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform
May-08-19	Reiterated	Barrington Research	Outperform
Aug-09-18	Reiterated	Barrington Research	Outperform
Feb-07-18	Reiterated	Barrington Research	Outperform
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-08-17	Reiterated	Barrington Research	Outperform
Aug-08-17	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-13-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Feb-07-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-08-16	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-07-16	Reiterated	The Benchmark Company	Hold
Sep-20-16	Downgrade	CJS Securities	Market Outperform → Market Perform
Aug-15-16	Downgrade	Sidoti	Buy → Neutral
Aug-02-16	Reiterated	Jefferies	Buy
Aug-02-16	Reiterated	The Benchmark Company	Hold

View All

Haemonetics Corp Stock (HAE) Latest News

Sep 27, 2024